Brief: Sinomab Bioscience Says Co Conditionally Agreed To Issue 56.8 Mln Subscription Shares
14/12/2023 15:26
Dec 14 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* CO CONDITIONALLY AGREED TO ISSUE AGGREGATE OF 56.8 MILLION
SUBSCRIPTION SHARES AT SUBSCRIPTION PRICE OF HK$1.29 EACH
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience